Interventional Cardiology & Peripheral Vascular Devices Market is expected to reach USD 31.47 billion by 2021

Tuesday, May 23, 2017 Heart Disease News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, May 22, 2017 /PRNewswire/ --

Highlights

  • The interventional cardiology
    and peripheral vascular devices market is expected to reach USD 31.47 billion by 2021 from USD 21.83 billion in 2016, at a CAGR of 7.1%.
  • In 2016, the IVUS/OCT segment is projected
    to witness the highest growth in this market due to increasing penetration rates and rapid advancements & innovations in these systems.
  • Growth in the North American region is primarily driven by the rising incidence of cardiovascular diseases, rapidly growing geriatric population, and technological advancements.
  • On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms.
  • In 2016, the abdominal aortic aneurysms segment is projected to witness the highest growth in this market due to the rising incidence of smoking and hypertension.
  • This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares.
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the interventional cardiology and peripheral vascular devices market.

The interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 billion by 2021 from USD 21.83 billion in 2016, at a CAGR of 7.1%. On the basis of product, this market is broadly classified into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories.

On the basis of type, the angioplasty stents market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. The drug-eluting stents segment is projected to witness the highest growth in this market due to increasing number of regulatory approvals and new product launches.

On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. In 2016, the IVUS/OCT segment is projected to witness the highest growth in this market due to increasing penetration rates and rapid advancements & innovations in these systems.

On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. In 2016, the abdominal aortic aneurysms segment is projected to witness the highest growth in this market due to the rising incidence of smoking and hypertension.

Geographically, the interventional cardiology and peripheral vascular devices market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American region is primarily driven by the rising incidence of cardiovascular diseases, rapidly growing geriatric population, and technological advancements.

Research Coverage: In addition to comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles in this report comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in the market. The abovementioned market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the interventional cardiology and peripheral vascular devices market.

The key players in the interventional cardiology and peripheral vascular devices market include Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan).

Reasons to Buy the Report: This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the product portfolios of the top players in the interventional cardiology and peripheral vascular devices market. The report analyses the interventional cardiology and peripheral vascular devices market by angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the interventional cardiology and peripheral vascular devices market - Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the interventional cardiology and peripheral vascular devices market- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various interventional cardiology and peripheral vascular devices across geographies - Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the interventional cardiology and peripheral vascular devices marketRead the full report: http://www.reportlinker.com/p04534881/Interventional-Cardiology-Peripheral-Vascular-Devices-Market-by-Type-Forecasts-to.html

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________Contact Clare: [email protected]US: (339)-368-6001Intl: +1 339-368-6001

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/interventional-cardiology--peripheral-vascular-devices-market-is-expected-to-reach-usd-3147-billion-by-2021-300461877.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook